D
Like Score · tier D4qualityScore▼0 · 7d
PriceFree
Reviews10388% positive
Inbound MLT2peers liking this
Lifetime units—no estimate
StatusLiveVery Positive
Sales estimate not available yet
Free-to-play title. Our sales estimator only covers paid games — F2P revenue (mostly DLC + microtransactions) needs a different methodology.
How sales estimation works →01 Like Score
qualityScore = Σ inbound · log₁₀(reviews+1) · positive% · rank-bonus
Tier D · ▼ 0 7d
D ●CBAS
Inbound
2
×
Σ log₁₀(R+1)
4
Avg pos%
87%
→ 4
Score history · 30d retention
5 (14d ago)4 (now)
02 Top inbound contributors
Games whose “More Like This” lists rank DERE EXE: Rebirth of Horror · 2 inbound · top 2 shown
qualityScore 4
03 DERE EXE: Rebirth of Horror’s “More like this”
Outbound MLT · 30 games
Review score
8/ 9
% positive
88.3%cohort 71%
Total reviews
103tracked
Velocity · 30d
0 / dayest
Steam-purchase rate
100.0%flat
01 Language distribution
Reviewer interface language · count, share of total, share positive
12 languages · top 12 shown
ENEnglish52.4%5489%
ZHSimplified Chinese13.6%14100%
RURussian10.7%11100%
PTBrazilian Portuguese4.9%5100%
TRTurkish4.9%560%
ESSpanish3.9%475%
ESLatin American Spanish2.9%367%
PLPolish1.9%2100%
KOKorean1.9%250%
FRFrench1.0%1100%
CZCzech1.0%10%
JAJapanese1.0%1100%
02 Reviews by playtime
Hours played at time of review · positive% per bucket
0-1h 49
84%positive
1-10h 52
92%positive
10-100h 2
100%positive
03 Monthly timeline
Reviews per month · positive vs negative stacked · since launch
Positive 91Negative 12
97520
21·0421·1022·0423·0223·0924·0625·0525·1226·04
04 Breakdowns
Reviews segmented · count, % of total, % positive
103 reviews
Free product
0/ 103
0.0% of total— no data
Early access
0/ 103
0.0% of total— no data
Key activation
0/ 103
0.0% of total— no data
Steam Deck
0/ 103
0.0% of total— no data
Steam purchase
103/ 103
100.0% of total88% positive
Recommended
91/ 103
88.3% of total— votedUp
Not recommended
12/ 103
11.7% of total— votedDown
Reviews crawled
103/ 103
100.0% of total88% positive
103 reviews · 88% positive
Detailed reviewer overlap is being computed. Check back soon.